Cargando…
The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: A case report
Remdesivir is a novel therapeutic with known activity against SARS CoV-2 and related coronaviruses. Remdesivir, as well as convalescent plasma therapy, are currently under investigation as potential therapies for patients with Coronavirus Disease 19 (COVID-19). In this case report we summarize the u...
Autores principales: | Anderson, Jonathon, Schauer, Jordan, Bryant, Suzanne, Graves, Cornelia R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229947/ https://www.ncbi.nlm.nih.gov/pubmed/32426243 http://dx.doi.org/10.1016/j.crwh.2020.e00221 |
Ejemplares similares
-
What's new in critical illness and injury science? Convalescent plasma for coronavirus disease-2019 patients with severe or critical illness
por: Miller, Andrew Carl, et al.
Publicado: (2021) -
Convalescent Plasma Therapy in Four Critically Ill Pediatric Patients With Coronavirus Disease 2019: A Case Series
por: Schwartz, Stephanie P., et al.
Publicado: (2020) -
Convalescent plasma is of limited clinical benefit in critically ill patients with coronavirus disease-2019: a cohort study
por: Huang, Li, et al.
Publicado: (2021) -
Convalescent Plasma Therapy for Coronavirus Disease 2019
por: Choi, Jun Yong
Publicado: (2020) -
WITHDRAWN: Remdesivir investigational trials in coronavirus disease 2019: a critical reappraisal()()
por: Brouqui, P., et al.
Publicado: (2020)